FIELD: medicine.
SUBSTANCE: invention relates to medicine and pharmaceutics, namely to a method for prediction of a stable virologic response to chronic hepatitis C therapy with preparations of direct antiviral action in the presence of lipid distress syndrome, including an immunological blood test with determination of the concentration of interleukin 4 and interferon gamma, characterized by that the patient is single-valued in the blood of the concentrations of interleukines 2 and 10, as well as biochemical blood examination and concentration of triglycerides and homocysteine, calculating the value of the discriminant function, comparing its value with a constant, and if the value is more than 275.107, the absence of a stable response is predicted, and if the value is less than or equal to 275.107, a stable virologic response is predicted.
EFFECT: technical result consists in providing a prediction of a stable virologic response to the therapy of chronic hepatitis C preparations of direct antiviral action in the presence of lipid distress syndrome by determining the patient's blood triglycerides concentration, homocysteine, interleukins 2, 4 and 10 and gamma-interferon.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF LIPID DISTRESS SYNDROME DEVELOPMENT IN PATIENTS WITH STABLE VIROLOGIC RESPONSE TO ANTIVIRAL THERAPY OF CHRONIC HEPATITIS C | 2019 |
|
RU2710264C1 |
METHOD FOR PREDICTION OF DEVELOPMENT OF LIPID DISTRESS SYNDROME IN CHRONIC VIRAL HEPATITIS C | 2019 |
|
RU2710254C1 |
METHOD FOR PREDICTION OF FORMATION OF VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C | 2011 |
|
RU2461834C1 |
METHOD FOR PREDICTION OF ANTIRETROVIRAL THERAPY OUTCOMES IN CHRONIC HEPATITIS B | 2014 |
|
RU2571493C2 |
METHOD FOR PREDICTION OF STABLE VIROLOGICAL RESPONSE TO ANTI-VIRAL THERAPY OF CHRONIC VIRAL HEPATITIS C ACCOMPANYING HIV INFECTION | 2013 |
|
RU2558793C2 |
METHOD FOR PREDICTION OF IF THERAPY EFFECTIVENESS FOR VIRAL HEPATITIS IN CHILDREN | 2008 |
|
RU2379689C1 |
METHOD FOR PREDICTION OF ANTIVIRAL THERAPY (AVT) EFFICACY IN CHRONIC HEPATITIS B (CHB) | 2011 |
|
RU2454666C1 |
METHOD FOR PREDICTION OF EFFICACY OF ANTIVIRAL TREATMENT OF CHRONIC VIRAL HEPATITIS C | 2013 |
|
RU2546032C2 |
METHOD FOR PREDICTING THE FLOW AND RESULTS OF ACUTE VIRAL HEPATITIS B AND C IN TEENAGERS | 2004 |
|
RU2268470C2 |
METHOD FOR EARLY PREDICTION OF CLINICAL OUTCOME OF ANTIVIRAL THERAPY FOR CHRONIC VIRAL HEPATITIS C | 2011 |
|
RU2480526C2 |
Authors
Dates
2019-12-25—Published
2019-10-01—Filed